Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancer
AuthorsGreen, Adèle C
Plasmeijer, E. I.
Chambers, D. C.
Ferguson, L. E.
Davis, M. B.
Whiteman, D. C.
Soyer, H. P.
AffiliationPopulation Health Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia. Adele.Green@qimrberghofer.edu.au.
MetadataShow full item record
AbstractVarious treatments of keratotic skin lesions and early skin cancers are performed in organ transplant recipients (OTRs) at high risk of skin malignancies but the frequency of their use is unknown. We prospectively assessed the frequency of use of cryotherapy, diathermy, and topical therapies and also investigated their associations with background incidence of histologically-confirmed squamous-cell carcinoma (SCC) and basal cell carcinoma (BCC) in a cohort of OTRs in Queensland, Australia. Median follow-up ranged from 1.7 to 3.2 years across organ transplant groups. Among 285 kidney, 125 lung and 203 liver transplant recipients [382 (62%) male, 380 (62%) immunosuppressed > 5 years, 394 (64%) previously diagnosed with skin cancer], 306 (50%) reported treatment of skin lesions with major types of non-excision therapies during follow-up: 278 (45%) cryotherapy or diathermy; 121 (20%) topical treatments. Of these 306, 150 (49%) developed SCC at double the incidence of those who did not receive these treatments, as assessed by incidence rate ratio (IRR) adjusted for age, sex, type of organ transplant, skin color and history of skin cancer at baseline, calculated by multivariable Poisson regression (IRRadj = 2.1, 95% confidence interval (CI) 1.4-3.1). BCC incidence was not associated with these therapies. Skin lesions in OTRs that are treated with cryotherapy, diathermy, or topical treatment warrant judicious selection and careful follow-up.
CitationGreen AC, Way M, Oster M, Plasmeijer EI, Jiyad Z, O'Rourke P, et al. Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancer. Arch Dermatol Res. 2020.
JournalArchives of Dermatological Research
- Topical photodynamic therapy of actinic keratosis in renal transplant recipients.
- Authors: Piaserico S, Belloni Fortina A, Rigotti P, Rossi B, Baldan N, Alaibac M, Marchini F
- Issue date: 2007 Jul-Aug
- Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
- Authors: Karia PS, Azzi JR, Heher EC, Hills VM, Schmults CD
- Issue date: 2016 May 1
- Management of organ transplant recipients attending a high-throughput skin cancer surgery and surveillance clinic in Queensland.
- Authors: Papier K, Gordon LG, Khosrotehrani K, Isbel N, Campbell S, Griffin A, Green AC
- Issue date: 2019 Mar
- Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia.
- Authors: Iannacone MR, Sinnya S, Pandeya N, Isbel N, Campbell S, Fawcett J, Soyer PH, Ferguson L, Davis M, Whiteman DC, Green AC, STAR Study.
- Issue date: 2016 Jul
- Painful skin lesions and squamous cell carcinoma predict overall mortality risk in organ transplant recipients: a cohort study.
- Authors: Oh CC, Hofbauer GFL, Serra AL, Harwood CA, Mitchell L, Proby CM, Olasz EB, Mosel DD, Piaserico S, Fortina AB, Geusau A, Jahn-Bassler K, Gerritsen MJP, Seçkin D, Güleç AT, Cetkovská P, Ricar J, Imko-Walczuk B, Dębska-Ślizień A, Bouwes Bavinck JN
- Issue date: 2017 May